|

Enpatoran Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: M5049

Pipeline

Phase 3: 2

Top Sponsors

  • EMD Serono Research & Development Institute, Inc.2

Indications

  • Lupus2
  • Systematic Lupus Erythematosus1
  • Cutaneous Lupus Erythematosus1
  • Cutaneous Lupus Erythematosus (CLE)1
  • Systemic Lupus Erythematosus (SLE)1

Los Angeles, California1 trial

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Dermatology Research Associates - 300204025

Phase 3

Upland, California1 trial

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Inland Rheumatology Clinical Trials, Inc.

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.